Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON46727Active, not recruiting
Randomised, double-blind trial of sodium oxybate + calcium oxybate + potassium oxybate + magnesium oxybate in narcolepsy (2 arms), sponsored by Jazz Pharmaceuticals plc. Primary endpoint: Ability to distinguish between JZP-258 and placebo for both replicates. Started Mar 2018; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON46727.